Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.

By S. Targan, B. Feagan, R. Fedorak, B. Lashner, R. Panaccione, D. Present, M. Spehlmann, P. Rutgeerts, Z. Tulassay, M. Volfová and 4 more. Gastroenterology, 2007

631 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/e4d08dee636344f65e12211e78df00c89932058a